Bosentan, sold under the brand name Tracleer, is a prescription medication used to treat pulmonary arterial hypertension (PAH). As a dual endothelin receptor antagonist (ERA), Bosentan works by relaxing the blood vessels in the lungs, helping to lower pulmonary blood pressure and improve the ability to exercise.
If you or a loved one is being treated for PAH, understanding how Bosentan works, its dosage guidelines, side effects, and safety requirements is essential for managing your condition effectively.
What Is Bosentan?
Bosentan is an oral medication that blocks endothelin-1 receptors (both type A and B). Endothelin-1 is a naturally occurring substance in the body that causes blood vessels to constrict. In people with PAH, excess endothelin-1 leads to high pressure in the arteries of the lungs, causing strain on the heart and difficulty breathing.
By blocking these receptors, bosentan helps:
- Widen blood vessels in the lungs
- Lower pulmonary arterial pressure
- Improve oxygen flow and physical stamina
- Slow progression of PAH symptoms
Bosentan is available in tablet form and is dispensed through specialty pharmacies due to its safety monitoring requirements.
FDA-Approved Uses of Bosentan
The U.S. Food and Drug Administration (FDA) has approved bosentan for the treatment of:
- Pulmonary Arterial Hypertension (PAH)
(World Health Organization Group 1) to improve exercise ability and delay clinical worsening
Approved for functional class II and III symptoms in both adults and children - Digital Ulcers in Systemic Sclerosis
In some regions (e.g., EU), bosentan is also approved to reduce the number of new digital ulcers in patients with systemic sclerosis
Bosentan may be used alone or in combination with other PAH medications, such as sildenafil or ambrisentan, depending on disease severity and treatment goals.
How Bosentan Works
Bosentan blocks endothelin type A and type B receptors, reducing the constriction of pulmonary blood vessels and decreasing inflammation in the lung vasculature.
Key benefits include:
- Lowering pulmonary vascular resistance (PVR)
- Improving right heart function
- Increasing exercise tolerance (measured by 6-minute walk test)
Unlike some PAH drugs that target a single receptor, bosentan’s dual receptor action provides broader control of disease progression.
Bosentan Dosage and Administration
Bosentan is taken orally twice daily, with or without food. Dosage may vary depending on the patient’s age, weight, and liver function.
Common Dosage Guidelines:
- Adults:
Initial dose: 62.5 mg twice daily for 4 weeks
Maintenance dose: 125 mg twice daily - Pediatric patients (weighing 10–40 kg):
Dose is weight-based and should be determined by a pediatric PAH specialist
Important: Dosage adjustments may be required for patients with liver impairment or those taking medications that affect bosentan metabolism.
Common Side Effects of Bosentan
Like all medications, bosentan can cause side effects. Most are manageable but require regular monitoring.
Common Side Effects:
- Headache
- Nasal congestion
- Respiratory infections
- Flushing
- Swelling of legs and ankles (peripheral edema)
Serious Side Effects:
- Liver toxicity (elevated liver enzymes)
- Anemia (low red blood cell count)
- Reduced sperm count in men
- Serious birth defects if used during pregnancy
Because of these risks, monthly blood tests are required to monitor liver function and hemoglobin levels during treatment.
Pregnancy and REMS Program Requirements
Bosentan is strictly contraindicated during pregnancy due to the risk of severe birth defects. For this reason, the FDA requires participation in the Bosentan REMS Program for:
- Women of childbearing potential
- Monthly pregnancy tests
- Mandatory contraception use
Prescribers, patients, and pharmacies must all be enrolled in the program to prescribe or dispense bosentan safely.
Access Through Specialty Pharmacies
Bosentan is dispensed only through certified specialty pharmacies due to the need for close monitoring. These pharmacies help ensure:
- Compliance with REMS requirements
- Regular lab monitoring reminders
- Insurance and copay assistance
- Delivery and refill coordination
Ask your healthcare provider for a referral to a specialty pharmacy to start bosentan treatment.
Conclusion
Bosentan (Tracleer) is an effective treatment for pulmonary arterial hypertension that helps lower blood pressure in the lungs, improve exercise ability, and delay disease progression. With proper dosing, regular monitoring, and participation in the REMS program, patients can safely benefit from this therapy. It remains a foundational option in the long-term management of PAH.
If you are considering bosentan as part of your PAH treatment plan, speak with your specialist or specialty pharmacist to ensure it’s appropriate for your condition and lifestyle.
